Wikidata

(Q63316112)

English

Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer

clinical trial

In more languages

Statements

short name
TESEGAST (English)
0 references
title
A Randomized, Double-blind Study of Capecitabine Plus Tesetaxel Versus Capecitabine Plus Placebo as Second-line Therapy in Subjects With Gastric Cancer (English)
0 references
country
Germany
0 references
Taiwan
0 references
start time
April 2012
0 references
end time
July 2014
0 references
number of participants
580
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63316112&oldid=2149393441"